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 Use of Cramer Rao bound criteria to optimize in vivo MR spectroscopy experiments 
 Method illustrated for 1D and 2D MRS, in particular 2D separation (2DJ) experiments 
 2DJ generalized to non-equidistant echo times and unequal numbers of scans per TE 
 Experiment optimizations discussed for GABA and glutamate as target metabolites 
 In vivo verification for sets of human brain spectra expanded by bootstrapping 
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Abstract 
Localized Magnetic Resonance Spectroscopy (MRS) is in widespread use for clinical brain 
research. Standard acquisition sequences to obtain one-dimensional spectra suffer from 
substantial overlap of spectral contributions from many metabolites. Therefore, specially tuned 
editing sequences or two-dimensional acquisition schemes are applied to extend the information 
content. Tuning specific acquisition parameters allows to make the sequences more efficient or 
more specific for certain target metabolites. Cramér-Rao bounds have been used in other fields 
for optimization of experiments and are now shown to be very useful as design criteria for 
localized MRS sequence optimization. The principle is illustrated for one- and two dimensional 
MRS, in particular the 2D separation experiment, where the usual restriction to equidistant echo 
time spacings and equal acquisition times per echo time can be abolished. Particular emphasis 
is placed on optimizing experiments for quantification of GABA and glutamate. The basic 
principles are verified by Monte Carlo simulations and in vivo for repeated acquisitions of 
generalized two-dimensional separation brain spectra obtained from healthy subjects and 
expanded by bootstrapping for better definition of the quantification uncertainties. 
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1. Introduction 
In vivo magnetic resonance spectroscopy (MRS1) allows for the in vivo and in situ quantitation of 
tissue metabolite contents. Different MRS techniques are available and the best suited 
technique in a particular situation depends on the target metabolites, the organ studied, the 
(patho-)physiological circumstances, as well as the experimental situation (in particular the B0 
field strength available). Given that metabolite signals in a proton MR spectrum usually have 
considerable overlap that makes the quantification difficult, generally, one of three different 
approaches is taken: 1) use of a single non-specific one-dimensional spectrum (e.g. a localized 
short echo time (TE) spectrum) followed by linear combination model fitting based on prior 
knowledge about the constituent metabolites and spectral parameters (Provencher, 1993; 
Ratiney et al., 2005; Slotboom et al., 1998; Wilson et al., 2011), or 2) use of a dedicated (so-
called editing) one-dimensional experiment optimized for exclusive or selective sensitivity for a 
single metabolite of interest, usually followed by simple model peak fitting or signal integration 
(Allen et al., 1997), or 3) use of a standard localized two-dimensional MR spectrum followed by 
peak integration (Thomas et al., 1996; Thomas et al., 2001) or prior knowledge fitting (Chong et 
al., 2011; Gonenc et al., 2010; Kiefer et al., 1998; Kreis et al., 2005; Schulte and Boesiger, 
2006; Thomas et al., 2008; van Ormondt et al., 1990; Vanhamme et al., 1999). In cases 1 and 
3, the choice of experimental parameters like TE and repetition time (TR) is most often based 
on general considerations about maximum signal for given relaxation times, insensitivity to 
changes in relaxation times or arguments about minimization of macromolecular baseline 
contributions, while in case 2 the signal yield of wanted and unwanted metabolites and their 
relative overlap is modeled based on quantum mechanical simulations or solution 
measurements.  
                                               
1
 Abbreviations used:  
2DJ: 2D-J separation Cr: creatine 
CRBs: Cramér-Rao minimum variance bounds FiTAID: Fitting Tool for Arrays of Interrelated Datasets 
FT: Fourier transformation GABA: -aminobutyric acid 
Gln: glutamine Glu: glutamate 
GSH: glutathione GW: Gaussian width 
HES: half echo sampling MES: maximum echo sampling 
MRS: magnetic resonance spectroscopy NAA: N-acetylaspartate 
PRESS: Point RESolved Spectroscopy TE: echo time 
TR: repetition time 
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An alternative route to arrive at optimal parameters for a particular experimental setting is to 
calculate the expected lower bound of the achievable precision for a range of potential 
experimental situations and select the experiment with best precision for the targeted 
metabolites. The so-called Cramér-Rao minimum variance bounds (CRBs) (Cavassila et al., 
2001) are an ideal measure for such an approach. CRBs provide a lower bound for the variance 
of fitted parameters and thus can be used as a measure for the maximum precision attainable 
by a specific experiment if the model for the data is complete and correct. In addition, they can 
be estimated without actually acquiring spectra, but purely based on a parameterized model 
function and the expected signal-to-noise ratio (SNR). This method of experiment optimization 
has been used in different fields (Anastasiou and Hall, 2004; Brihuega-Moreno et al., 2003; 
Ober et al., 2002) but only preliminary results of its use for in vivo MRS have been reported 
(Bolliger et al., 2012; Chong et al., 2007; Snyder and Lange, 2012).  
 
To demonstrate the principle, we investigated the optimization of localized one- and two-
dimensional spin echo experiments of human brain. The one-dimensional case corresponds to 
the clinically most frequently used localization sequence, PRESS (Point RESolved 
Spectroscopy (Bottomley, 1984)), with the echo time as an optimizable parameter and with a 
linear combination model of basis sets as evaluation tool. Simultaneous evaluation of multiple 
spectra with differing echo times corresponds to 2D J-separation spectroscopy (2DJ MRS or J-
PRESS) (Aue et al., 1976; Kreis and Boesch, 1994; Thomas et al., 1996; Thomas et al., 2003), 
where a series of PRESS scans is acquired with TE incremented by a fixed step size, thus 
obtaining a two-dimensional dataset, which is usually Fourier transformed in both dimensions 
before evaluation. 2DJ-MRS has been recommended (Roussel et al., 2010; Schulte et al., 2006) 
for simultaneous quantification of brain metabolites, and it has been claimed previously (Gonenc 
et al., 2010) that in particular the quantification of coupled metabolites is improved with 2DJ 
compared to 1D experiments. The benefit of acquiring multiple echo data in single shots and 
Monte Carlo parameter optimization in view of a compromise between spectral resolution and 
added information from multiple echoes was described in Ref. (Kiefer et al., 1998). 
Here, 2DJ experiments are considered where no Fourier transformation (FT) is applied in the 
second dimension and which can be evaluated with a linear combination model with prior 
knowledge relations like in the 1D case using FiTAID (Fitting Tool for Arrays of Interrelated 
Datasets) (Chong et al., 2011). This provides the freedom to combine scans of arbitrary echo 
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times (i.e. not equally-spaced timings) and arbitrary number of scans per TE. This so-called 
generalized 2DJ experiment was thus optimized with CRBs criteria for optimal precision for a 
targeted set of metabolites. 
Acquiring a series of PRESS scans with varying TEs has two main advantages over single short 
TE experiments: First, it allows for the fitting of transverse relaxation times and second, J-
coupled spins undergo J-evolution, which leads to specific spectral patterns as function of TE 
(or cross-peaks in 2D spectra after double FT) and therefore better discrimination between 
metabolites. Short TE scans have the advantage of a higher signal-to-noise ratio, but this 
comes at the expense of large underlying macromolecular signals. Due to their short transverse 
relaxation time compared to metabolites, it is possible to eliminate macromolecular signals by 
using long enough TE while maintaining metabolite signals – though they are evidently reduced 
by relaxation and phase dispersion through J-evolution, as well. Therefore, sampling short as 
well as long echo times in one experiment may possibly improve the discrimination of 
macromolecules and metabolites. 
Here, we propose the principle of using CRBs for MRS experiment design and illustrate it by 
determining whether short TE spectra, conventional, or generalized 2DJ scans are the best for 
the quantitation of specific brain metabolites.  Additionally, the question was addressed  which 
TE to use in 1D MRS and which maximum TE and TE spacing are best suited in conventional 
2DJ scans for the quantitation of the metabolites of interest. Exemplary interest was placed on 
-aminobutyric acid (GABA), glutamate (Glu), glutamine (Gln) and glutathione (GSH). Model 
simulations were used to identify general characteristics, while in vivo spectra were recorded to 
demonstrate the general validity of this design approach. In order to document small 
improvements in quantification precision in vivo, a large number of repeated measurements in 
human subjects is needed. However, the scan time that can be tolerated by individual subjects 
is limited. Therefore the number of repeated measurements was extended artificially by 
bootstrapping (Efron, 1979), which has turned out to be a very useful technique to estimate 
probability distributions and has previously been used in in vivo MRS in order to estimate errors 
of fitting parameters (Bolan et al., 2004) based on resampled subsets of individually stored 
single MRS acquisitions.  
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2. Material and Methods 
2.1. Estimation of CRBs 
CRBs provide a lower bound of the standard deviation   for the parameters  of a model 
function  fitted to experimental data by minimizing , provided that the parameter estimator is 
unbiased and the SNR is above a certain threshold (Vallisneri, 2008). For the estimator to be 
unbiased and thus for the CRBs to yield valid bounds for the physical variables described by the 
fitting parameters, the model has to be correct and the minimization procedure has to provide 
the global minimum. Besides, the model has to be fully parameterized. The CRBs are obtained 
using the Fisher information matrix , by extracting the roots of the corresponding diagonal 
elements of its inverse: 
 [Eq. 1] 
As described in Ref.(Cavassila et al., 2001),  can be calculated by taking the real part of a 
complex-valued matrix product: 
 , [Eq.2] 
where  denotes Hermitian conjugation. The columns of the matrix  are partial derivatives of 
the discretized model function  (where  denotes the data point index of the measured data, 
possibly a multi-dimensional index) with respect to the fitted parameters 
 ,  [Eq. 3] 
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where  is the standard deviation of the noise at the respective data point. Here, we assume 
equal standard deviations at all data points, i.e. = , thus the CRBs depend linearly on . 
In order to obtain the matrix 2 , the partial derivatives should be evaluated at the true 
parameter values. In practice, however, these values are unknown and  is estimated with fitted 
parameter values.  
In addition, the information matrix is invariant under FT of the data since the FT preserves the 
inner product. Therefore, CRBs can be calculated in either time or frequency domain. This 
applies to both, the directly measured dimension and the indirect (second) dimension. 
In the context of trying to understand which particular subsets of 2DJ data are most relevant for 
generalized 2DJ experiments, it is worthwhile to note that the inverse of the diagonal elements 
of the Fisher matrix provide a lower bound to the respective CRB, since for any positive definite 
matrix it can be shown that . (The proof is presented in the inline supplement 
P.1.) 
Furthermore, in the case of a complete model, decreasing the number of data points by 
selecting a limited data range in any dimension cannot decrease the CRBs. (inline supplement 
P.2 contains the proof for the equivalent statement that extending the data range from a 
selected region leads to decreased or at least invariant CRBs).  
2.2. Specific model function 
While the principle of using CRBs criteria to optimize experimental parameters is valid for 
arbitrary experiments and independent of the formulation of the signal model (as long as it is 
                                               
2
 Typically, in a valid model, the rows of  are linearly independent and hence the corresponding Fisher 
information matrix is positive definite and the inverse exists. However, under certain circumstances it is 
possible that the Fisher matrix becomes singular (or nearly singular, i.e. ill-conditioned), in which case  
in equation [1] can be replaced by the Moore-Penrose pseudoinverse  of  (Vallisneri, 2008). This is 
usually a sign that prior knowledge should be applied to the parameters that cause the singularity.  
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complete and correct), a localized 2DJ experiment and the model function as previously defined 
in Ref. (Chong et al., 2011) was used to illustrate the claim. In short, the model describes a two-
dimensional parameterized function consisting of a linear composition of simulated two-
dimensional basis sets  where  is an index usually referring to the different two 
dimensional basis spectra of the included metabolites and the superscript  symbolizes the 
fact that the basis spectra refer to numeric patterns. Often the basis sets are linked by prior 
knowledge constraints in both dimensions. For half echo sampling (HES), they can be explicitly 
summarized as: 
 
 [Eq. 4] 
where the area ( ) 3, phase ( ), transversal relaxation time ( ), and the Gaussian width 
( ) are fitting parameters for the individual basis functions. Introducing prior knowledge 
reduces the number of free parameters. In the specific models used below, the Gaussian widths 
were identical for all metabolites (representing field inhomogeneities affecting all metabolites 
equally), and the T2s of all coupled spins were linked to a common T2 parameter, resulting in 
only 5 different T2s in the model. 
For data acquired with maximum echo sampling (MES) (Kiefer et al., 1998; Macura and Brown, 
1983; Schulte et al., 2006), the model has to be adjusted. More precisely, for a time domain 
signal for which data sampling was started  before the echo maximum, the model is adjusted 
as follows: 
                                               
3
 We refer to A, the time domain signal amplitude, as (frequency domain) area parameter, rather than 
amplitude, while the word amplitude is used for the frequency domain peak amplitude. 
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 [Eq. 5] 
Note that HES corresponds to MES with an echo delay  of 0 ms:   
.  [Eq. 6] 
Basis spectra  for 18 metabolites were simulated for 3T in GAVA (Soher et 
al., 2007), using chemical shifts and J-couplings from Refs. (Govindaraju et al., 2000) and 
(Tchong Len et al., 2004). Of major importance in the current context is the modeling of the 
macromolecular baseline (MMBL). In order for the concept of CRBs use for experiment 
optimization to be valid, the MMBL must be included in a parameterized form (or reliably and 
accurately be eliminated in preprocessing) (Cudalbu et al., 2012). As in Ref. (Chong et al., 
2011), an experimentally measured MMBL was included, parameterized as equally spaced 
Voigt lines with sets of common line widths and T2s. 
Calculation of CRBs and general data processing was performed in matlab version 7.4.0 
R2007a (Mathworks, Natick, Massachusetts, U.S.A.). The data was fitted as a 2D-array without 
FT along the second dimension. 
2.3. Optimization of experimental parameters 
Optimal experiments were designed by calculation of expected CRBs for a large set of 
conventional and generalized 2DJ experiments based on the model function described in 2.2 
and specified below. The optimizations were performed for typical in vivo conditions of human 
brain. In particular, the following parameter values were used: 
a) linewidth parameters chosen to correspond to typical values as obtained from fitting 2DJ 
datasets recorded from a volume in occipital human gray matter (Gaussian line width of 4 Hz 
and natural linewidths ( ) for metabolites ranging from 1.0 to 2.5 Hz) 
10 
 
b) area parameter values selected to correspond to typical metabolite concentrations, and 
c) the MMBL described as three partially linked subparts as in Ref. (Chong et al., 2011). 
For all PRESS experiments considered here, the time interval between the 90° pulse and the 
first 180° pulse was kept fixed at 6 ms, and for MES the signal acquisition started 5 ms after the 
second 180° pulse, such that . Thus, for these settings HES coincides with 
MES  at TE=22 ms.  
2.3.1. 1D MRS and conventional 2DJ scans 
In order to determine the longest echo time to be included and to find optimal TE spacings, 
CRBs were estimated for all possible 1D and 2DJ experiments with a lower limit for TE of 
22 ms, TE step sizes of 0 or multiples of 2 ms, and an upper limit for TE of 322 ms. HES, as 
well as MES, was considered. For a meaningful comparison, experiments with equal acquisition 
time have to be evaluated, thus, the standard deviation of the noise for the estimation of the 
CRBs was scaled by , where  is the number of TE steps. 
2.3.2. Generalized 2DJ scans 
Based on the longest TE found to be relevant in paragraph 2.3.1, minimal CRBs were searched 
in a set of generalized 2DJ experiments. This search covered all generalized 2DJ experiments 
with 8 scans and TEs in an interval between 22 ms and 202 ms, with values included with a 
step size of 12 ms, also allowing multiple scans with identical TE.  
Experiments yielding minimal CRBs for GABA, Glu, Gln and GSH were identified as well as an 
experiment dedicated to GABA and Glu quantification, where the experiment with minimal CRB 
for Glu was selected from all experiments with GABA CRBs that were at most 1% larger than 
the GABA optimum. 
2.4. Factors influencing optima in experiment design  
Optima of generalized experiments were obtained for a number of different situations to 
evaluate dependences between these factors and the CRB optima. The following five factors 
were investigated by searching for optima in specific experiment or model situations: 
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1. MES: half vs. maximum echo sampling. 
2. Shim: varying the Gaussian linewidth from 2, to 4, 6, and 8 Hz. 
3. T2 estimation: inclusion vs. exclusion of T2s as fitting variables. 
4. MMBL estimation: inclusion vs. exclusion of the MMBL as fitting parameters.  
5. Model complexity: hypothetical simple situation of only 5 metabolites without MMBL vs. 
the full model. In this case, only the areas of the 5 metabolites were fitting parameters. 
2.5. Verification on simulated data 
The improvement in quantification precision predicted by the respective CRBs was verified in a 
first step on simulated data. For an optimized and a conventional 2DJ experiment, a set of 130 
spectra each was constructed by adding different noise realizations to the model data. 
The optimized experiment considered was the generalized 2DJ found to be optimal for Glu 
quantitation (for which the acquisition of the signal for TE=22 ms was repeated 6 times and the 
echo times of 58 ms and 202 ms were acquired once each), and the echo times considered for 
the conventional 2DJ experiment were 22 ms up to 246 ms, incremented in steps of 32 ms. In 
both cases, MES was assumed. The noise added to the data was realized as white Gaussian 
noise, such that an SNR of 45.6 (defined by the maximum peak amplitude (methyl singlet of 
NAA) at TE=22 ms) was obtained.  
A power analysis for the F-test was used to calculate the sample size needed to prove that the 
variance in the results for Glu is smaller from the generalized 2DJ experiment than from the 
conventional 2DJ. For the expected difference in standard deviations (20% decrease), a 
significance level  of 0.05, and a power of 0.8, the minimum sample size came out to be 126 
for each 2DJ variant (Lenth, 2012).   
The parameters for each simulated experiment were fitted in FiTAID, where basis spectra 
simulated for 18 metabolites with Voigt lineshapes were applied and where the Lorentzian 
widths were coupled with the respective T2s. Only 5 different metabolite T2s were introduced: a 
common T2 for all multiplets, and individual T2s for the singlets of Cr, NAA, and total choline.  
Standard deviations for the fitted Glu concentrations were calculated. In order to exclude effects 
of those cases where the fitting procedure terminated in a local  minimum, outliers were 
excluded by removing values that lay outside the mean ±2 standard deviations of the whole set 
and were outside of the range defined by the mean ± 3 standard deviations of the reduced set. 
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The one-sided F-Test was used to compare the variances of the Glu area parameters obtained 
from the selected conventional and generalized 2DJ scans 
2.6. In vivo verification 
In order to verify the predicted precision improvement in vivo, human brain spectra were 
recorded in 8 healthy subjects (6 female, 2 male, age 35.0 12.9 years) from a region of interest 
of 15.4 cm3 in occipital grey matter on a 3T Siemens Trio scanner using a quadrature 
transmit/receive head coil. The standard 2DJ experiment (8 TEs from 22 to 246 ms, in steps of 
32 ms, 16 acquisitions per TE), as well as an optimized generalized experiment (TEs of 22ms, 
22ms, 58ms, 22ms, 22ms, 202ms, 22ms, and 22ms, 16 acquisitions per TE), was recorded for 
each subject 6 times in an interleaved fashion (5.5 min acquisition time each, TR 2.5 s) in a 
single session. MES was used, as described in chapter 2.3. Metabolite cycling (MacMillan et al., 
2011) was applied instead of water presaturation in order to obtain the metabolite and reference 
spectra simultaneously. Post processing included adding/subtracting the metabolite-cycled 
scans to obtain metabolite and water spectra (used for eddy current correction) and Hankel-
Lanczos Singular Value Decomposition (Pijnappel et al., 1992) to eliminate the residual water 
signal. 
Bootstrapping was used to create 25 out of the recorded 6 datasets for both the standard and 
the optimized experiment in each subject. Each data point of the bootstrapped spectra was 
obtained by random sampling from the corresponding 6 complex-valued data points of the 
(frequency-aligned and post-processed) original spectra. Each spectrum was fitted 
independently with FiTAID as described above in chapter 2.5, except for an additional overall 
shift parameter. The bootstrap estimate of the standard deviations of the fitted parameters, i.e. 
the variance of the bootstrapped dataset, was used as an approximation of the true standard 
deviation, which yields a more precise approximation than the variance of the original data 
based on 6 values only. Outlier removal was performed as described earlier, and a general 
linear model was applied for the fitted parameter of interest to determine the experimental 
variance  controlling for inter-individual differences in metabolite content.  
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3. Results  
3.1. Optimization of experimental parameters 
3.1.1.  1D PRESS and conventional 2DJ MRS 
CRBs optimization of experimental conditions is first illustrated for standard single TE spectra. 
Exemplary results for the optimization of 1D PRESS experiments are shown in Figure 1. The 
CRBs are plotted for 3 metabolites as a function of TE (full lines). Both traditional half echo 
sampling (Fig 1a) and MES (Fig 1b) were investigated. In both cases, there is no monotonic 
increase of CRBs with TE in spite of the decreasing signal due to T2 relaxation. With HES, short 
TEs are advantageous for all presented metabolites. In particular, the shortest TE clearly yields 
the lowest CRB for Glu, while for NAA, where the spectrum is dominated by the monotonously 
decreasing singlet signal, the CRB increase is weaker with increasing TE. For GABA, however, 
the CRBs decrease somewhat with echo times from 22 ms to around 110 ms.  
When MES is applied, the CRBs are lowest at different TE values for each metabolite, clearly 
suggesting different optimal acquisition conditions for each metabolite. In particular, for the 
specific fitting conditions (i.e. prior knowledge, known MMBL form, and fixed T2s) the use of the 
shortest available TE is only optimal for the determination of Glu, while for GABA the use of 
fairly long TEs yields lower CRBs. Minima are reached for TEs around 100 and 190 ms. In the 
case of NAA, shorter echo times are beneficial, not only for HES, but also MES.  
The CRBs are bounded from below by the inverse square root of the integrated power of the 
partial derivative function (for area parameters, the latter corresponds to the basis function 
itself). To motivate some of the TE dependence of the CRBs, this lower bound is included in 
Figure 1 as dashed line. The difference between these values and the CRBs is due to the 
correlations between fitted parameters. 
For conventional 2DJ experiments, it was first evaluated up to which maximum TE data 
sampling should be extended and second what echo spacing would prove to be most efficient. 
In Figure 2, the estimated CRBs of conventional 2DJ experiments are plotted versus the 
maximum sampled TE in the case of dense sampling (2 ms step size). For GABA, the CRBs 
reach minima at 128 ms (HES) and at 208 ms (MES). With HES, the single short TE experiment 
is best for Glu, but for MES the minimum CRB is reached at 94 ms, with hardly any substantial 
14 
 
further change for maximum TEs up to around 200 ms. Above this value, the CRBs increase 
steadily. Interestingly, an almost monotonic exponential decrease of CRBs is observed for NAA 
in the cases of HES as well as MES. Up to maximum TEs of ~100 ms, the decrease in CRBs is 
fast.  
In the bottom row of Figure 2, the ratio in CRBs for MES versus HES is illustrated as a function 
of maximum TE. MES is beneficial for all metabolites and all TEs. The decrease in CRBs for 
maximum TEs above 200 ms is as much as 25%. 
The influence of step size and maximum TE on CRBs for conventional 2DJ experiments (with 
MES) can be appreciated from Figure 3. In the upper row, the CRBs for three metabolite areas 
and a linewidth are plotted versus the maximum TE for different step sizes. Below, the CRBs of 
a subset of these experiments are drawn as a function of step size. It seems that fine sampling 
is beneficial for GABA, whereas for the other parameters coarser sampling yields lower CRBs. 
For Lorentzian widths, and hence, T2s, CRBs decrease monotonically with increasing maximum 
TE, though only with little further improvements above 200 ms.  
Apparently, including maximum TEs larger than 200 ms is not efficient, not even when taking 
into account larger step sizes. Hence, a maximum TE of 202 ms was chosen for the 
optimization of generalized 2DJ experiments with MES. 
Some quantitative results for the optimization of conventional 2DJ scans are assembled in the 
upper part of Table 1 for the strongly coupled metabolites GABA, Glu, Gln, and GSH. CRB 
based parameter optimization found the largest potential for improvement for Glu, with a 16% 
CRB decrease relative to the reference experiment. For GABA, this improvement was only a 
few percent. As illustrated in Figure 4, optimal conventional 2DJ experiments for Glu, Gln and 
GSH consist of only two or three echo times with coarse TE sampling. As already evident from 
Figure 3, the quantitation of GABA benefits from finer TE sampling. 
3.1.2. Generalized 2DJ MRS 
The expected precision improvements for generalized vs. conventional PRESS and 2DJ 
experiments are illustrated in the bottom part of Table 1 and Figure 4. Only small further 
improvements can be achieved by generalizing the TE spacings and the distribution of 
acquisition time per TE. The quantitation of Glu and GABA benefit most from generalization with 
decreases in CRBs  of 5 % and 4 %, respectively, while for Gln and GSH hardly any 
15 
 
improvement can be achieved. For the quantitation of Glu and Gln, experiments consisting of a 
combination of several repetitions of the shortest TE and shorter measurements of longer TEs 
are favorable, whereas for GABA and GSH the emphasis is on longer TE (see Fig. 4). Table 1 
illustrates also that optimizing experimental conditions for one metabolite often worsens the 
precision for others. If several metabolites are of interest, other experiments that compromise 
for the set of metabolites can be chosen. If one is, for example, mostly interested in the 
neurotransmitters GABA and Glu, one might opt for the experiment listed in the last row, which 
was found as the best setup for Glu among those scans that are within 1% of the optimum 
achievable for GABA.  This compromise yields almost the maximum improvement for GABA 
with hardly any penalty for Glu (or the other listed metabolites).  
3.2. Effects of model/experiment on optima 
The extent of the CRBs improvement and the optimal experimental parameters found for any 
specific metabolite depend on the exact experimental or model situation considered. To 
demonstrate this, generalized 2DJ experiments optimized for the quantification of 3 different 
metabolites are depicted in Figure 5 for various scenarios. The figure also shows percentage 
CRBs improvements for each case in relation to its own corresponding conventional 2DJ 
experiment with TEs from 22 ms to 246 ms. 
HES was compared to MES, both for the full model and for a simplified case of only 5 
metabolites (see Methods, all with GW of 4Hz). In both cases, it was found that optimized 
experiments tend to include shorter TEs in the case of HES. In addition, the potential for CRBs 
improvements is clearly larger for HES than MES, which is mostly due to the fact that there is 
larger SNR loss for HES than MES with increasing TE.  
The influence of line broadening (shim performance) on the optimal scans can be seen from the 
comparison of the evaluations for models with different Gaussian widths. For broader lines, the 
shortest TE scans are weighed less, probably because of the larger correlation between 
metabolites and the MMBL. In agreement with this, the shortest TE tends to have more weight if 
the MMBL is not fitted (assumed to be known or removed in a preprocessing step).  
If T2 relaxation times are not fitted but kept fixed (possibly taken from a cohort average) the 
scans with the longest TEs lose importance and are replaced with shorter TE scans that have 
less T2-weighting. 
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If the model complexity is reduced to the inclusion of only 5 metabolite areas, the optimal 
experiments change noticeably, but there does not seem to be a clear trend on how they 
change.  
In addition, there are some metabolite-specific observations. For GABA, in the case of MES, the 
single TE PRESS experiment with TE=166 ms is superior to all generalized 2DJ experiments in 
the case where only the area parameters of five metabolites are fitted. This TE is also 
distinctively present in the optimized experiments when more parameters are fitted or when the 
Gaussian line width is varied. For HES, the most relevant TE seems to be 94 ms. However, the 
overall potential for improvement seems to be rather small for GABA. 
For Glu, in all cases a combination of repeated measurements at the shortest TE combined with 
fewer scans at longer TE is optimal. These experiments decrease the CRBs by 20% and more 
for most cases. The optimal experiments for the quantitation of NAA show similar patterns, 
though with a slightly lower potential for improvement. 
3.3. Verification on simulated data 
Monte Carlo fits of an in silico dataset, where the ground truth is known, were used to test 
whether the improvement in estimation precision, as predicted by the CRBs criterion used in 
experiment design, does indeed hold. The CRB for Glu quantification was expected to be 7.9% 
and 5.6% for the conventional and the optimized experiments. Least squares optimizations in 
130 experiments each yielded coefficients of variance for the two cases of 5.6% and 4.0% and 
showed that there was no significant bias of the estimated concentrations in either experiment. 
The one-sided F-test showed that the variance of the fitted Glu concentrations for the optimized 
experiment is significantly lower than for the conventional 2DJ experiment (p=0.0005). 
3.4. In vivo verification 
The same experiments were tested also on in vivo data acquired in 6 measurements in 8 
subjects. In Figure 6, sample spectra obtained for the conventional and the generalized 2DJ 
experiment optimized for Glu are presented (6 spectra with TE=22 ms plotted as an average 
with improved SNR). The six repeats per subject were extended to 25 pseudo-repeats by 
bootstrapping (see Methods for details and the inline electronic supplement for a figure to 
illustrate this procedure).  The results for Glu from 2D model fitting of the conventional and the 
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generalized 2DJ experiments in 8 subjects are presented in Figure 7. The quantitative analysis 
of the fitted Glu concentrations confirmed the prediction. The coefficient of variance decreased 
to 66% of the value obtained for the conventional experiment, while the CRBs calculations had 
forecast an improvement of the variance to 80%. 
4. Discussion  
CRBs provide well-suited criteria to select optimal sampling strategies for many applications and 
fields. Here, it was shown that the CRBs criteria can be very beneficial for the optimization of 
acquisition parameters of localization and quantification sequences used in clinical MRS and in 
combination with linear combination model fitting. In particular, this was illustrated for the 
optimization of 2D experiments targeted at specific individual or groups of metabolites of interest 
in neuroresearch. 
The proposed principle is valid for any MRS technique where the results are obtained by 
unbiased least squares fitting with a complete model. As shown in the examples, specific 
potential for CRBs as design criteria is not only found for complex experiments like the 
generalized 2DJ, but even for the most standard 1D localization sequence in clinical use. 
However, the basic principle was illustrated primarily for the more complex situation of the 2D J 
separation experiment that is becoming more and more popular in brain research at clinical field 
strengths for a simultaneous and more accurate determination of coupled metabolites. 
Conventional or generalized 2DJ experiments, i.e. acquisitions of a series of PRESS scans with 
varying TEs, have several advantages over single short TE experiments: First, they provide for 
determination of transverse relaxation times. Second, because J-coupled spins show 
specifically varying spectral patterns as function of TE (or cross-peaks in doubly Fourier-
transformed 2D spectra), 2DJ has the potential for better discrimination between metabolites. 
And third, 2DJ experiments benefit from maximum-echo sampling where signal acquisition 
starts immediately after the last RF pulse rather than at the echo maximum (Kiefer et al., 1998; 
Macura and Brown, 1983; Schulte et al., 2006). Here, it was demonstrated how acquisition 
parameters for conventional and generalized 2DJ experiments can be optimized in order to 
manifest the purported advantages. Expected CRBs were estimated for a set of experiments 
and those with minimal CRB for a parameter of interest were considered optimal. Optima 
depend on which metabolites are prioritized, but also on experimental circumstances, like shim 
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quality, or on whether or not the MMBL or metabolite T2s are expected to change or are 
assumed to be constant.  
In terms of specific optimization results, it is most noteworthy that it has been shown 
quantitatively that MES provides a large benefit for all metabolites and that careful selection of 
the maximum TE and the TE spacing in conventional 2DJ can substantially lower the CRBs 
further. For the typical in vivo T2 values, the maximum useful TE amounted to about 200 ms in 
the case of MES and fairly large TE spacing seemed optimal for most metabolites. 
Generalization of the 2DJ sampling strategy did not lead to dramatic further improvements. 
Interestingly, optimal experiments for Glu and NAA contain at least one scan with the shortest 
TE of 22 ms, but this is not the case for GABA, which is in agreement with the optimized single 
TE experiments and a recent study (Napolitano et al., 2013). It is certainly of note that optimal 
1D experiments for some metabolites may ask for longer echo times and that also for the 1D 
experiments one may well benefit from MES, a strategy that is currently hardly ever pursued. 
It should be stressed that the estimated CRBs are strictly only valid for the specific 
circumstances considered (e.g. field strength, ideal RF pulses, line width, metabolite set) and 
the case of a complete model where the treatment of the baseline is crucial. This certainly limits 
this approach for experiment design, however, being able to finetune the acquisition strategy to 
the exact experimental situation (e.g. field strength), or postprocessing strategy, is also an 
advantage. For example, it makes sense to use different experiments whether or not the T2s or 
MMBL will be treated as unknown. 
The inverse of the square root of the diagonal elements of the Fisher matrix do not depend on 
the prior knowledge applied to the other parameters and provide a lower bound to the 
respective CRBs. They might thus be used as an approximation. However, conclusions from 
this approximation can be misleading, as seen in the case of GABA. 
Alternative methods for parameter optimizations mostly aiming at specific metabolites have 
often been based on finding the best acquisition parameters for optimal target signal yield but 
also with minimal spectral overlap between the target and nuisance signals (Choi et al., 2010; 
Choi et al., 2012; Hu et al., 2007; Kim et al., 2005; Snyder and Wilman, 2010), usually based on 
quantum mechanical simulations and in vitro experiments. These investigations certainly have 
the advantage of yielding basic understanding of why certain parameter settings are optimal, but 
the CRBs inherently provide a tool that includes these optimization criteria and also extends 
them to other interfering metabolites and experimental factors. 
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One considerable advantage of the proposed strategy is the possibility to optimize experiments 
not just for single but also for multiple metabolites. If the optimum for two parameters is 
targeted, an approach as presented for the quantification of GABA and Glu can be chosen, 
where the experiment yielding minimal CRB for Glu has been selected from all experiments 
yielding close to the minimal CRB for GABA. As an alternative, or if the optimum for a larger set 
of parameters is required, criteria used in multi-objective optimization, such as Pareto-optimality 
(Bolliger et al., 2011) or weighted sums, can be applied to choose the optimal experiment.  
It should be noted that CRBs, if calculated with the full data range in both domains, do not 
depend on whether FT is applied in the 2nd dimension or not. Furthermore, in the case of a 
complete model, neglecting any information leads to an increase in CRBs. Therefore, restriction 
of 2 calculation to off-diagonal areas (in the 2D FT case) does not help - on the contrary. This 
might be different if the model is incomplete (e.g. unknown baseline that cannot properly be 
parameterized) and off-diagonal regions in the 2D spectrum might be virtually unaffected by the 
unknown baseline components that interfere in the overall model.  
The verification of the proposed strategy of experiment optimization was performed in two steps 
for a specific 2DJ experiment optimized for quantification of Glu: First, using synthetic spectra 
where the true parameter values are known, and second for in vivo spectra. In the latter case, 
where the number of experiments that can be acquired per volunteer is limited, bootstrapping 
was used to artificially increase the number of experiments acquired for every volunteer for a 
better estimation of the variance of the fitted parameters. However, this approach cannot be 
used to artificially expand on the number of volunteers because inter-individual differences 
interfere with bootstrapping. It should be noted that in absolute terms the standard deviations 
obtained with bootstrapping are slightly lower than the true values because of induced 
correlations. However, for performance comparison of the two experimental settings, standard 
deviations from bootstrapped data are perfectly valid. 
Both verification approaches confirmed the improvement of quantitation precision that had been 
predicted by the CRBs estimations, which were based solely on a theoretical model. Using the 
synthetic model, where the true parameter values were known (and corresponded exactly to the 
values used for the CRBs estimation), it was shown that the accuracy of the fitted parameters 
was not degraded by using the optimized experiment. The improvement in quantitation precision 
in the in vivo case was in surprisingly good agreement with the prediction, in spite of the 
differences between the parameter values used for CRBs estimation and the fitted parameters, 
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and in spite of the limitations in the model, like the description of the macromolecular baseline 
as a set of mono-exponentially decaying Voigt lines, which is not true as known from GABA 
editing (Henry et al., 2001).  
5. Conclusions 
Localized MR spectroscopy experiments can be optimized for best use of scan time for 
particular target metabolites using Cramér-Rao bounds criteria. Specifically, for conventional 
2DJ experiments, best maximum TE to be included and best echo spacing can objectively be 
defined. Furthermore, CRBs criteria can be used to generalize the 2DJ experiment to allow 
unequal echo spacing and unequal number of acquisitions per TE. The benefit of maximum 
echo sampling has been documented quantitatively, not only for 2DJ, but also common 1D 
PRESS. The principle of experiment design based on CRBs optimization has been illustrated 
and verified with artificial spectra, but also in vivo brain spectra where the parameter 
optimization was documented with the expected improvement of variance in fitting results for 
Glu. It was also shown that bootstrapping can be used to effectively extend the measurement 
time beyond what is normally tolerable by human subjects. The CRBs method has clear limits 
that have to be respected, including the need for a correct model and full model 
parameterization.  
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6. Tables 
Table 1:  
Relative Cramér- Rao minimum variance bounds for selected experiments as presented in Fig. 
4 and scaled for equal scan time. CRB values for all included area parameters are listed as 
relative values with respect to the corresponding CRBs in the default conventional 2DJ 
experiment provided in the top trace.. Further rows contain conventional 2DJ experiments 
optimized for the metabolite listed in the first column; the darker shaded area contains  
generalized 2DJ experiments optimized for either individual metabolites, or in the lowest row for 
GABA and Glu (cf. text). All scans include MES and T2 fitting. 
7. Figure captions 
Figure 1:  
Cramér- Rao minimum variance bounds for 1D single TE scans.  CRBs for single TE PRESS 
experiments are plotted as function of TE (solid lines) for three representative metabolite area 
parameters. The inverse square roots of the diagonal elements of the Fisher matrix (dashed 
line) provide a lower bound to the respective CRBs. The CRBs are expressed relative to the 
CRB value obtained for TE 22 ms.  The upper row corresponds to half echo sampling and the 
lower row to maximum echo sampling. (Lorentzian widths not fitted, note the different scales for 
HES and MES). 
 
Figure 2:  
Cramér- Rao minimum variance bounds for conventional 2DJ experiments as function of 
maximum TE. The graphs show the influence of the maximum TE for each experiment on the 
CRBs for the area parameters of the same metabolites as in Fig. 1 for dense TE sampling (step 
size of 2 ms) but assuming equal total experiment duration (relative scaling for CRBs as in 
Fig. 1). The difference of MES (blue) vs. HES (red) is already evident in the top row and is 
further illustrated quantitatively in the lower row. 
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Figure 3:  
Cramér- Rao minimum variance bounds for conventional 2DJ experiments as function of 
maximum TE and TE sampling density.  Row a) shows relative CRB values of all sampled 2DJ 
experiments as a function of the maximal TE, while row b) zooms into the subset of experiments 
with maximum TE between 180 and 220 ms (blue rectangle in the upper row) and shows these 
selected CRBs as a function of TE step size (relative scaling for CRBs as in Fig. 1). CRBs for 
three metabolite areas and one linewidth parameter are shown. The data are color-coded 
depending on the number of steps: darker colored dots refer to finely-sampled 2DJ, brighter 
dots to a coarser sampling. Example: experiment consisting of TEs 22, 36, 50 ms  max TE = 
50ms, TE step = 14 ms, number of steps = 3. An extended version of this figure can be found in 
the electronic supplement (ES1). 
 
Figure 4:  
Experimental schemes for the optimized experiments listed in Table 1.  Each row represents a 
2DJ experiment consisting of different TE scans as described in Table 1. The TE values used 
are given by number (in ms) and the width of each field represents the scan time dedicated to a 
specific TE. 
 
Figure 5:  
Pictorial representation of generalized 2DJ experiments optimized for GABA, Glu and NAA 
under different model situations.  2DJ experiments are depicted as histograms of the rate of use 
for each TE, hence the height of the bars represents how often the respective TE was sampled 
(maximum height corresponds to 8 repetitions, e.g., the top left graph represents a 2DJ 
experiment with 6 scans at TE 22, one scan at TE 94, and one scan at TE 118 ms). The 
different rows correspond to different model or acquisition conditions as stated on the left and 
representing: 
 GW 2 Hz to 8 Hz: models with increasing overall Gaussian width (decreasing shim 
quality). 
 no T2: model with fixed T2s (not fitted). 
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 no MMBL: model with fixed MMBL contribution, no MMBL related parameters fitted. 
 5 met: strongly simplified model with only 5 metabolites and 5 free parameters (area 
parameters of Cr, GABA, Glu, Gln and NAA). 
Blue and red graphs represent MES and HES, respectively. The values on top of the bar plots 
stand for the percentage CRB decrease achieved for this case in comparison to the 
conventional 2DJ experiment with TEs from 22 ms to 246 ms, in steps of 32 ms (with the same 
model settings and acquisition scheme (HES or MES)). 
 
Figure 6:  
Representative conventional and generalized 2DJ spectra recorded from human grey matter in 
a healthy subject.  The spectra obtained with MES and plotted in magnitude mode correspond 
to a conventional (A, TE 22 to 246 ms, 16 acquisitions per TE) and a generalized 2DJ 
experiment optimized for Glu (B, see 3rd row in Fig. 5). The higher scan time spent on TE 22 ms 
is evident from the lower noise in that spectrum. 
. 
Figure 7:  
Glutamate content as obtained from 2D fitting of conventional and optimized generalized 2DJ 
spectra for volunteers A to H.  The bars represent average values ± 1 standard deviation for the 
fitted Glu concentration. Left: conventional 2DJ experiment, right: optimized experiment (cf. Fig. 
6). Evaluations with (orange) and without bootstrapping (black) are given. 
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P. Mathematical Proofs 
P1. Lower bound for diagonal elements of the inverse of a positive-definite 
matrix  
The inverse of the square root of the diagonal elements of the Fisher matrix provide a lower 
bound to the respective CRB. 
Statement:  
For any positive definite matrix , the following holds: 
 [Eq. A1] 
Proof:  
Let  be the eigenvalue decomposition of F, where  is the unitary matrix 
( ) whose columns are the normalized eigenvectors (orthogonalized for 
eigenvalues of multiplicity greater than 1) and  is the diagonal matrix whose main diagonal 
contains the corresponding eigenvalues .  
It follows that  . 
Thus we conclude that 
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 Here we used that  for any . 
 P2.  CRB cannot be decreased by neglecting information  
Increasing the number of data points is reflected in adding rows to the matrix of partial 
derivatives  and thus adding a positive-semidefinite matrix to the original (positive-definite) 
information matrix, which leads to decreased or unchanged values on the diagonal of the 
inverse (and thus CRB) . Conversely, neglecting information may lead to an increase in CRB, 
but never to a decrease. 
Statement:  
For a positive-definite matrix  and a positive-semidefinite matrix  it holds that  
  [Eq. A2] 
with equality if and only if all eigenvalues of  are zero (  is nilpotent). 
Proof:  
Let  be the eigenvalue decomposition of F, where  is the unitary matrix whose 
columns are the normalized eigenvectors and  is the diagonal matrix whose main diagonal 
contains the corresponding eigenvalues .  
Defining , and  as the -th column vector of , we can write 
, and thus  
. 
Further, we define  by  and write 
 where we introduced the eigenvalue decomposition 
 , with  and 
  (since  and thus are positive semi-definite). 
It follows that  with ,  
and hence the diagonal elements can be written as  
 .  
 is a Hermitian matrix with eigenvalues  
Expressing  in the basis of eigenvectors of , i.e.  and thus , yields: 
 
as required. 
 
 F: Figures 
Figure ES1: 
Cramér- Rao minimum variance bounds for conventional 2DJ experiments as function of 
maximum TE and TE sampling density.  Row a) shows relative CRB values of all sampled 2DJ 
experiments as a function of the maximal TE, while row b) zooms into the subset of experiments 
with maximum TE between 180 and 220 ms (blue rectangle in the upper row) and shows these 
selected CRBs as a function of TE step size (relative scaling for CRBs as in Fig. 1). In this 
extension of Fig. 3 CRBs for four metabolite areas and two linewidth parameters are shown. 
The data are color-coded depending on the number of steps:  darker colored dots refer to finely-
sampled 2DJ, brighter dots to a coarser sampling. Example: experiment consisting of TEs 22, 
36, 50 ms  max TE = 50ms, TE step = 14 ms, number of steps = 3.  
 
Figure ES2:  
Single spectra from 2DJ datasets illustrating the bootstrapping method used to extend the 
number of repeated experiments to determine the coefficient of variance for fitted Glu when 
comparing conventional with optimized 2DJ.  On the left the spectra with TE 22 ms from each of 
the repeated generalized 2DJ spectra (c.f. Fig. 7 B) is plotted for one subject, while on the right, 
the 25 corresponding spectra obtained by bootstrapping are depicted, where each data point 
(for all TEs) was randomly picked from one of the six original 2D spectra 
 
